3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Breast
1
Conditions
Brain Neoplasms
8
Glioblastoma
4
Meningioma
3
Delirium
2
Central Nervous System Diseases
2
Breast Neoplasms
2
Water-Electrolyte Imbalance
1
Spinal Cord Neoplasms
1
Seizures
1
Radiation Injuries
1
Neuroinflammatory Diseases
1
Neurocognitive Disorders
1
Melanoma
1
Lung Neoplasms
1
Hypoxia
1
Hemorrhage
1
Gliosarcoma
1
Glioma
1
Gastrointestinal Neoplasms
1
Gangliosidosis, GM1
1
Gangliosidoses
1
Colorectal Neoplasms
1
Cognitive Dysfunction
1
Acid-Base Imbalance
1
Interventions
Patient Reported Outcome Measures
2
Neuropsychological Tests
2
lithium sulfate
1
XENP 1595
1
Tablets
1
Sodium Chloride
1
Ramipril
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Quality of Life
1
Pioglitazone
1
Metformin
1
Mental Status and Dementia Tests
1
Memantine
1
Lithium
1
G(M1) Ganglioside
1
Donepezil
1
Climate Anxiety
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cognitive Dysfunction
×
Sodium Chloride
×
CNS
×
Clear all
NCT04395339
2024-08-01
GLORY
Sun Yat-sen University
Phase 3
Terminated
51 enrolled